Quality & complianceOfficial

FDA lists Class II recall of Victory Medical Center Pharmacy tirzepatide/niacinamide injection

🇺🇸 FDA enforcement report · Wed 11 Nov 2026

The enforcement report entry cites a lack of processing controls for the 20/2 mg/mL, 3 mL product; the recall is ongoing in Colorado, Florida and Texas.

The US Food and Drug Administration has published a Class II drug recall in its enforcement report, covering tirzepatide/niacinamide (MDV) 20/2 mg/mL, 3 mL, from Victory Medical Center Pharmacy. The entry is dated 11 November 2026 and carries recall number D-0154-2027.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: FDA enforcement report ↗

Article written by VigiEye from the official source (FDA enforcement report). AI-assisted; check the source before acting.